By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lexicon Pharmaceuticals, Inc. 

8800 Technology Forest Place

The Woodlands  Texas  77381-1160  U.S.A.
Phone: 281-863-3000 Fax: 281-863-8088



Company News
Lexicon Pharma (LXRX) To Report Third Quarter 2016 Financial Results On November 1, 2016 10/25/2016 9:28:49 AM
Lexicon Pharma (LXRX) Reports Positive Top-Line Results In Phase 2 Dose-Ranging Study For Sotagliflozin In Patients With Type 1 Diabetes 10/25/2016 6:47:34 AM
Lexicon Pharma (LXRX) Announces Agreement To Buy Out Remaining Obligations To Symphony Icon, Inc. 10/5/2016 6:32:37 AM
Lexicon Pharma (LXRX) Release: Telecast Data Presented At The 2016 North American Neuroendocrine Tumor Society Annual Symposium 10/3/2016 8:45:41 AM
Lexicon Pharma (LXRX) Release: FDA Extends PDUFA Date For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome 9/15/2016 8:58:56 AM
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data 9/9/2016 6:18:17 AM
Lexicon Pharma (LXRX) To Present At The Bank of America (BAC) Merrill Lynch Global Health Care Conference 9/8/2016 10:01:28 AM
Lexicon Pharma (LXRX) To Present At The 2016 Wedbush PacGrow Healthcare Conference 8/12/2016 11:47:31 AM
Lexicon Pharma (LXRX) Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results 8/4/2016 8:34:41 AM
Lexicon Pharma (LXRX) To Report Second Quarter 2016 Financial Results On August 4, 2016 8/2/2016 7:34:54 AM